Azuma arata (18 risultati)
Editore: Akebono shobo, 1953
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. The book is in fine condition.
Editore: Akebono shobo, 1954
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. Number of books:s.
Editore: Akebono shobo, 1954
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. Number of books:s.
Editore: Akebono shobo, 1954
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. Number of books:s.
Editore: Akebono shobo, 1954
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. The book is in fine condition.
Editore: Akebono shobo, 1954
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 56,33
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. The book is in fine condition.

Lingua: Inglese
Editore: Birkhäuser, 2017
- Rilegato
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 172,45
EUR 35,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibile
Buch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.…

Lingua: Inglese
Editore: Birkhäuser, 2017
- Rilegato
Da: Buchpark, Trebbin, GermaniaBuchpark
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Ottimo
AffarePrezzo corrente: EUR 112,00
EUR 105,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibile
Condizione: Sehr gut. Zustand: Sehr gut | Seiten: 272 | Sprache: Englisch | Produktart: Bücher | This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.…

Lingua: Inglese
Editore: Springer, 2017
- Rilegato
Da: Books Puddle, Woodside, NY, U.S.A.Books Puddle
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 221,74
EUR 3,64 spedizioneSpedito in U.S.A.Quantità: 4 disponibili
Condizione: New.

Lingua: Inglese
Editore: Birkh?user, 2017
- Rilegato
Da: Home-set, Mannheim, GermaniaHome-set
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 187,24
EUR 49,90 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Gebundene Ausgabe. Condizione: Neu. This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals. Sprache: Englisch Gewicht in Gramm: 574.…

Lingua: Inglese
Editore: Springer, 2017
- Rilegato
Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 334,45
EUR 29,95 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibile
Hardcover. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Editore: Kosakusha, china, 1969
- Brossura
Da: Sunny Day Bookstore, SINGAPORE, SingaporeSunny Day Bookstore
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Ottimo
EUR 280,70
EUR 13,67 spedizioneSpedito da Singapore a U.S.A.Quantità: 1 disponibile
Aggiungi al carrelloCondizione: Fine. The book is in fine condition.

Lingua: Inglese
Editore: Springer, 2017
- Rilegato
- Print on Demand
Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 118,26
EUR 6,80 spedizioneSpedito da Italia a U.S.A.Quantità: Più di 20 disponibili
Condizione: new. Questo è un articolo print on demand.

Lingua: Inglese
Editore: Springer Basel AG Feb 2017, 2017
- Rilegato
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 149,79
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Buch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals. 263 pp. Englisch.…

Lingua: Inglese
Editore: Springer Basel, 2017
- Rilegato
- Print on Demand
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 127,40
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Gebunden. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Offers up-to-date information on the research background and treatment of these pulmonary diseasesExplores basic molecular biological research as well as clinical applicationsPrimarily aimed at researchers and clinicians.…

Lingua: Inglese
Editore: Springer Basel, Birkhäuser Feb 2017, 2017
- Rilegato
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 149,79
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibile
Buch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -This volume describes the pathogenesis and pathophysiology of several pulmonary diseases as well as their treatment. It also discusses the underlying genetic and molecular biological basis, which opens the way for new treatments for these conditions.It focuses on the treatment of cystic fibrosis including CFTR (cystic fibrosis transmembrane-conductance regulator) modulator therapies, drug therapies that augment airway surface liquid as well as anti-inflammatory and anti-infective therapies. Further topics include long-term, low-dose macrolide therapy for diffuse panbronchiolitis; novel agents for previously untreatable idiopathic pulmonary fibrosis; possible new treatments for pulmonary alveolar proteinosis (PAP); and multiple novel therapeutic targets for treating lymphangiomyomatosis. Research into these conditions has led to major advances in our understanding of the underlying genetic and molecular basis of this disease, and to dramatic improvements in survival and quality of life for affected individuals.Springer Nature c/o IBS, Benzstrasse 21, 48619 Heek 272 pp. Englisch.…

Lingua: Inglese
Editore: Springer, 2017
- Rilegato
- Print on Demand
Da: Majestic Books, Hounslow, Regno UnitoMajestic Books
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 232,87
EUR 7,79 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 4 disponibili
Condizione: New. Print on Demand This item is printed on demand.

Lingua: Inglese
Editore: Springer, 2017
- Rilegato
- Print on Demand
Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 231,09
EUR 9,95 spedizioneSpedito da Germania a U.S.A.Quantità: 4 disponibili
Condizione: New. PRINT ON DEMAND.